Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence

BACKGROUND: According to the Response Assessment in Neuro-Oncology criteria, new enhancement within the radiation field on contrast enhanced T1-weighted images within 12 weeks after completion of radiotherapy should not qualify for progressive disease, since up to 50% of these cases may be pseudopro...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Radbruch, Alexander, Fladt, Joachim, Kickingereder, Philipp, Wiestler, Benedikt, Nowosielski, Martha, Bäumer, Philipp, Schlemmer, Heinz-Peter, Wick, Antje, Heiland, Sabine, Wick, Wolfgang, Bendszus, Martin
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2015
Pynciau:
Imaging
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4483046/
https://ncbi.nlm.nih.gov/pubmed/25038253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou129
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg